Member Info for Mozax

In fairness it was my comment, cut and pasted by Rocket.

So the ticks go to me.

First time I’ve managed to tick my own comment.

Eeerrrr yes, that’s why the volume has increased considerably but the SP isn’t moving up.

Substantial holders have very recently added significant sums to their holdings.

Undoubtedly with some knowledge on the matter.

I’m pleased with developments here, they’ve won back the IML’s, raised a chunk of Capital at 4.25p which was offered voluntarily, and now have ‘several’ parties interested in funding the project to production.

And today offers an opportunity to buy at a large discount to the big boys, not often that happens.!!

The discussions are continuing, but not on an exclusive basis, I see that as a positive.

You don’t want to negotiate whilst being held over a barrel.

Let’s see who is ‘The additional interest’, perhaps the Australian investors know something we don’t, you don’t just add another £500K to your holdings without some knowledge.

Rockets post earlier:

“Directors were buying at 80p and this hit 150p on FDA approval. Patent protected until 2035 in a 100 billion dollar liquid biopsy field.”

Good post Rocket, and Yes, remember, the “ $100 Billion liquid biopsy field is the US alone”!!

Think India, China, Japan etc etc!!!!!

Watch the bounce.

Always an opportunity to get into a stock, short termers looking for a trade in other pharmas, but they’ll be back in here later.

25 Million traded already, lovely dip to buy.

Oh dear.

I’m still accumulating here.

Volume is up considerably, this can move quickly as LTH’s know.

Nuvecs’s use as an Oral Delivery Technology.

“Further news on this will be announced in The New Year”

No they wont.

The $100 Billion is a figure taken from 14th July RNS in 2022.

It’s not a pump, it’s a fact.

Click on your posting history and all you ever say is the same thing.

For those without L2 this is already up 16.2% with 37p on the ask.

WNTS have moved to 41p.

And it’s only 9 am.

Yes, it’s going to get interesting, this news is so massive that it hasn’t been fully digested by many.

Journalists are going to be all over this so I expect some serious coverage this weekend.

Next week could see some big moves up.

Last night I hadn’t heard of ‘Liquid Biopsy’ but researched like a demon and have been buying like mad on the sell off this morning.

Liquid Biopsy Market in the US alone.

“Parsortix system is the ONLY liquid Biopsy solution with FDA product clearance for harvesting intact cancer cells from patient blood for analysis”

Now have a re-think on value here.

It was only sold down to 28.5p, buyer demand is there and already bounced back to 31p within 30 mins.

The key here is to hold these for longer than a day.

Surprisingly large returns to be made here for the even slightly impatient.

Of course, profit will be taken.

But the amount of buyers who will want in here will be phenomenal, remember, word has only just got out.

Weekend papers will cover this, Directors buying at 80p in the last Capital raise,

Remember, “liquid biopsy market is a growing and emerging market and is estimated to be worth over $100 Billion in the US alone.” (RNS 5591S 14th July 2022)

The Parsortix system is only the third liquid biopsy solution with FDA product clearance & is the FIRST & ONLY FDA product clearance for harvesting intact cancer cells from patient blood for subsequent analysis.

Try getting in at these levels on Monday.

This was undervalued when it was 12p, the market hasn’t recognised the fact that this isn’t a drug that’s being developed, it’s a vehicle in which to transport endless drugs, vaccines, genes etc.

What I like here as an investor, is I believe we will have the opportunity to tie up numerous licensing deals with various pharmaceutical Companies, enabling ongoing huge revenue streams.

‘Nuvec’ has been years in development and with each trial the potential grows.

“A potentially massive opportunity”

……”and further news on this will be announced in the New Year”

From the 18th December RNS 0368X

I’m of the opinion that N4P could get very big, very quickly, many years of work now coming together.

Seems to be a consistent seller here, perhaps a TR1 due?

Down 18% without news?